Dr. Ziwen Long 龙子雯
Chief Physician, Teaching Assistant
Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of gastric cancer, gastroesophageal junction tumors, and retroperitoneal tumors. Specializes in minimally invasive and endoscopic treatments for gastric tumors, as well as comprehensive treatment for advanced gastric cancer.
Dr. Long is a Chief Physician and Master’s Supervisor at Fudan University Shanghai Cancer Center. Trained under Professors Wang Yanong and Shi Yingqiang, Dr. Long focuses on clinical care and basic research for gastric cancer, gastrointestinal stromal tumors, and retroperitoneal tumors.
Professional roles
- Member, Youth Committee on Gastrointestinal Stromal Tumors, China Anti-Cancer Association
- Member, Gastric Cancer Professional Committee, Shanghai Anti-Cancer Association
- Member, Laparoscopic Specialist Committee for Gastrointestinal Tumors; Member, Cancer Prevention and Screening Specialist Committee
- Director, Shanghai Physicians Volunteer Association
Name order: in Chinese the family name comes first (Long Ziwen). Papers usually list the name as Ziwen Long or Long Z.
Selected publications
51 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- JACC CardioOncol, 2025 (first author): Shared Pathways, Shared Predictions: Cardiovascular Health and Risk Metrics in the Context of Cancer Risk. PubMed 40841110
- Cancer Biomark, 2022 (senior author): Human mesenchymal stem cell derived exosomes inhibit the survival of human melanoma cells through modulating miR-138-5p/SOX4 pathway. PubMed 35275523
- Front Cell Dev Biol, 2020 (senior author): RNF180 Inhibits Proliferation and Promotes Apoptosis of Colorectal Cancer Through Ubiquitination of WISP1. PubMed 33553163
- J Cell Biochem, 2019 (senior author): Comparative efficacy and safety of antiplatelet agents in cerebral ischemic disease: A network meta-analysis. PubMed 28409870
- Cancer Biol Ther, 2018 (senior author): A mixed treatment comparison of toxicity of gemcitabine combined with different targeted drugs in the treatment of advanced or metastatic pancreatic cancer. PubMed 29658816
- Mol Cells, 2018 (first author): MiR-374b Promotes Proliferation and Inhibits Apoptosis of Human GIST Cells by Inhibiting PTEN through Activation of the PI3K/Akt Pathway. PubMed 29902839
- J Cell Physiol, 2018 (senior author): MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B. PubMed 29893409
- J Cell Biochem, 2017 (senior author): Efficacy and Safety of Single- or Double-Drug Antidiabetic Regimens in the Treatment of Type 2 Diabetes Mellitus: A Network Meta-Analysis. PubMed 28471499
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion